The 90-Day Diagnostic is a structured engagement designed to determine whether earlier visibility into middle-layer organizational health creates a meaningful intervention window — before costs are locked in.
Why we start with a diagnostic
The 90-Day Diagnostic is how health systems begin with SenterME. It gives both sides a bounded period to test fit, evaluate the signal, and determine whether a longer-term partnership makes sense.
What This Diagnostic Answers
Signal Validity
A critical assumption underlying the Diagnostic is that middle-layer participants will sustain voluntary self-reporting over a 90-day observation window. SenterME has direct behavioral evidence validating this assumption — before a single institutional deployment was run.
Prior to institutional deployment, SenterME's signal capture platform was validated in a consumer context targeting high-performance individuals managing burnout risk. That cohort sustained voluntary check-in rates exceeding twice per week throughout the observation period — without push notifications, reminders, or incentives.
Investment
Starting at $25,000. Most health systems choose the expanded diagnostic because it gives leadership enough scope to compare variation across units, facilities, or service lines rather than relying on a single contained snapshot.
What You Receive
The Diagnostic produces four outputs across the 90-day observation window. Each deliverable is designed to keep executive and operational leadership oriented as patterns emerge — without requiring action before evidence is sufficient.
What Leadership Knows at Close
This diagnostic is designed to build evidence on your system, in your context. It is not a promise of outcomes. It is a bounded test of whether earlier structural visibility changes what leadership can see and govern.
Risk Instrument
Healthcare buyers are operating under heavy labor and margin pressure. The diagnostic investment is small relative to the financial exposure attached to workforce instability — and a fraction of what a single preventable attrition event costs.
We'll walk through how the diagnostic works, which scope fits your health system, and what the evidence would look like for your specific structural context. No pitch deck. Just a real conversation.
Book a Demo →Zero workflow disruption · No PHI · No individual scoring · Fully reversible · NPG 12 compliance evidence included